Captrust Financial Advisors Corcept Therapeutics Inc Transaction History

Captrust Financial Advisors

  • $34.2 Billion
  • Q4 2024

A detailed history of Captrust Financial Advisors transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Captrust Financial Advisors holds 113,988 shares of CORT stock, worth $6.69 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
113,988
Previous 103,740 9.88%
Holding current value
$6.69 Million
Previous $4.8 Million 19.67%
% of portfolio
0.02%
Previous 0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
BUY
$44.66 - $60.85 $457,675 - $623,590
10,248 Added 9.88%
113,988 $5.74 Million
Q3 2024

Nov 14, 2024
SELL
$29.51 - $46.26 $568,215 - $890,736
-19,255 Reduced 15.66%
103,740 $4.8 Million
Q2 2024

Aug 14, 2024
SELL
$22.21 - $34.48 $148,273 - $230,188
-6,676 Reduced 5.15%
122,995 $4 Million
Q1 2024

May 15, 2024
SELL
$21.1 - $27.46 $261,661 - $340,531
-12,401 Reduced 8.73%
129,671 $3.27 Million
Q4 2023

Feb 14, 2024
SELL
$24.82 - $32.88 $22,536 - $29,855
-908 Reduced 0.64%
142,072 $4.61 Million
Q3 2023

Nov 14, 2023
SELL
$21.97 - $33.8 $1.87 Million - $2.88 Million
-85,187 Reduced 37.34%
142,980 $3.9 Million
Q2 2023

Aug 14, 2023
BUY
$21.44 - $25.15 $13,314 - $15,618
621 Added 0.27%
228,167 $5.08 Million
Q1 2023

May 15, 2023
BUY
$19.2 - $24.47 $4.01 Million - $5.11 Million
208,844 Added 1116.69%
227,546 $4.93 Million
Q4 2022

Feb 15, 2023
BUY
$19.95 - $29.96 $2,932 - $4,404
147 Added 0.79%
18,702 $379,000
Q3 2022

Nov 16, 2022
BUY
$24.7 - $29.12 $269,798 - $318,077
10,923 Added 143.12%
18,555 $476,000
Q2 2022

Aug 23, 2022
SELL
$17.33 - $25.3 $119,074 - $173,836
-6,871 Reduced 47.38%
7,632 $181,000
Q2 2022

Aug 16, 2022
BUY
$17.33 - $25.3 $133,406 - $194,759
7,698 Added 113.12%
14,503 $345,000
Q1 2022

May 16, 2022
BUY
$16.53 - $25.21 $52,581 - $80,193
3,181 Added 87.78%
6,805 $153,000
Q4 2021

Feb 14, 2022
BUY
$17.1 - $23.34 $4,377 - $5,975
256 Added 7.6%
3,624 $72,000
Q3 2021

Nov 16, 2021
BUY
$19.68 - $22.53 $728 - $833
37 Added 1.11%
3,368 $66,000
Q2 2021

Aug 16, 2021
SELL
$19.97 - $24.43 $12,860 - $15,732
-644 Reduced 16.2%
3,331 $73,000
Q1 2021

May 17, 2021
BUY
$23.49 - $30.56 $88,204 - $114,752
3,755 Added 1706.82%
3,975 $95,000
Q4 2020

Feb 16, 2021
BUY
$16.78 - $27.3 $1,678 - $2,730
100 Added 83.33%
220 $6,000
Q3 2020

Nov 17, 2020
BUY
$12.46 - $19.98 $1,495 - $2,397
120 New
120 $2,000

Others Institutions Holding CORT

# of Institutions
403
Shares Held
84.3M
Call Options Held
1.04M
Put Options Held
1.33M
View Full List

About CORCEPT THERAPEUTICS INC

CORT Quotes by TradingView
  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $6.28B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Captrust Financial Advisors Portfolio

Follow Captrust Financial Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email